Navigation Links
Celltrion and CSL Announce Collaboration to Develop and Manufacture Monoclonal Antibody
Date:1/10/2008

INCHEON, South Korea, Jan. 10 /PRNewswire/ -- Celltrion, Inc., a Korean biopharmaceutical company whose core business is currently contract manufacturing, and CSL Limited, Australia's leading biopharmaceutical company, announced today the signing of an agreement for the development and supply of CSL 360, an experimental monoclonal antibody therapy for the treatment of acute myeloid leukemia (AML). Phase I clinical trials for CSL 360 are currently being conducted by CSL in Australia.

As part of the collaboration, Celltrion will provide process development expertise and supply clinical and commercial material to support the clinical development program for CSL 360 and commercialization of the product, with the potential for a longer term strategic manufacturing relationship between the companies in the future.

"Celltrion and its employees are completely committed to world-class quality in biopharmaceutical manufacturing, to assisting CSL in achieving the successful completion of clinical trials, and to providing manufacturing support for CSL's product commercialization," said Jung-Jin Seo, Celltrion's Chairman and Chief Executive Officer.

"Superior quality biopharmaceutical manufacturing facilities of this type are a scarce commodity in this region and we are delighted to have signed this collaboration to provide CSL with the opportunity to facilitate the clinical development of CSL 360 and potentially other exciting future recombinant protein opportunities," said Dr. Brian McNamee, CSL's Chief Executive Officer.

About Celltrion

Celltrion, established in 2002, is a contract manufacturing organization with a headquarters in Incheon, South Korea. Celltrion, an emerging leader in the biopharmaceutical industry, is dedicated to providing high quality services to accelerate product development, while offering scalable manufacturing capabilities for our clients and business partners. Celltrion is also investing in research and devel
'/>"/>

SOURCE Celltrion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... Nov. 21, 2014  Particle Sciences, Inc (PSI), ... developed and manufactured a new innovative vaginal ring ... and Development arm of Exeltis Pharmaceuticals.  According to ... Management at Particle Sciences, "This vaginal ring was ... material sciences and modeling expertise.  We are thrilled ...
(Date:11/21/2014)... and VIENNA, Va. , Nov. 21, ... provider that operates in Southern California ... of remote caregiving technology. Alta will be providing the ... receiving homecare services. Logo - http://photos.prnewswire.com/prnh/20141121/160143LOGO ... the key to providing the kind of affordable 24/7 ...
(Date:11/21/2014)... 2014  Heated dialogue in recent months about the ... treatments to Gilead,s new hepatitis C drug Harvoni® – ... questioning what it means to put a price on ... And while drug pricing is one of the most ... a general business and ethical standpoint – it is ...
Breaking Medicine Technology:Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring 2Alta Home Care, Inc. and BeClose Partner to Enable Seniors to Remain in Their Homes Safely and Securely 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 3"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 4"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 5
... clinical studies; Data to be presented at AACR ... discovery and development company Esperance Pharmaceuticals today presented ... that support the initiation of clinical trials in ... Company,s Cationic Lytic Peptide (CLYP(TM)) platform technology. EP-100 ...
... FREDERICK, Md., April 21 ImQuest BioSciences and ... of funding from the National Institutes of Health ... therapeutics for the treatment of hepatitis C virus ... therapeutic potential and mechanism of action of ATI-0810 ...
Cached Medicine Technology:First Candidate from Esperance's Targeted Anti-cancer Platform, EP-100, Establishes Preclinical Proof of Concept 2First Candidate from Esperance's Targeted Anti-cancer Platform, EP-100, Establishes Preclinical Proof of Concept 3ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent 2
(Date:11/24/2014)... Richmond, Virginia (PRWEB) November 24, 2014 ... taking center stage in this year’s SENIORS GOT TALENT, ... Seniors Guide. , From piano players to classic crooners, ... it’s clear that older adults are indeed living young. ... of competition because there’s a cash prize, has always ...
(Date:11/24/2014)... Recently, SweetDressy.com, a well-known dress supplier and ... of 2014 Evening Dresses. All these fresh items are ... marketing manager, the special offer is valid until Dec. ... Sweetdressy.com has been working well in the fashion industry ... designs. Their new dresses may be the best products ...
(Date:11/24/2014)... Mental health issues affect tens of ... families, ruin careers, and generally destroy lives. , ... suffer,” says Hardy Nutritionals® founder David ... specialized nutritional treatments can reverse these disorders naturally.” ... Matter”, the premiere episode of O2 Media’s new ...
(Date:11/24/2014)... (PRWEB) November 24, 2014 ReAdmission ... and disease management services to health plans, hospitals, ... Essette’s Medical Management software suite. ReAdmission Solutions ... in a program to reduce patients' avoidable readmissions ... Health Management, Care Management, Utilization Management, and Appeals ...
(Date:11/24/2014)... (PRWEB) November 24, 2014 "My friend ... was trying to cross the street in his motorized ... never saw him. I came up with this idea ... at night." , He developed the Safety Lites to ... in low-lighting conditions. The device ensures that motorists can ...
Breaking Medicine News(10 mins):Health News:Nursing Homes & Assisted Living Retirement Communities Enter Seniors Guide's Seniors Got Talent 2Health News:Nursing Homes & Assisted Living Retirement Communities Enter Seniors Guide's Seniors Got Talent 3Health News:SweetDressy.com Unveiled A New Selection Of Evening Dresses 2Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 2Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 3Health News:ReAdmission Solutions, LLC Selects Essette 2
... a bird flu exercise Tuesday in which all ... to a human,influenza pandemic. ,Senior officials from ... a hypothetical scenario in the "APEC Pandemic Response,Exercise ... a series that will prepare the,emergency management sector ...
... rates, the Centre has asked the state governments to launch ... initiative for polio immunisation. // ,Breast feeding alone ... is not only the best food for the child but ... Secretary Women and Child Development Reva Nayyar said., ,Nayyar ...
... cigarette smoking was found to weaken the bones and increases ... long been known to increase the risk for osteoporosis in ... one in China, find that smoking also hastens the erosion ... the first time, that even second-hand smoke can significantly increase ...
... mental illness, which was under-diagnosed till now was found ... was thought before//. Intermittent Explosive Disorder or Rage disorder ... violent outbursts. This illness if left untreated may also ... ,Intermittent Explosive Disorder attacks are out of proportion ...
... Maternity and Child Health Hospital and local health and ... with 2,000 6-to-7-year-old children, revealed that number of overweight ... cent are overweight. ,Xia Li, vice-dean of ... Hospital says since the past 10 years the ratio ...
... sentenced to a month's imprisonment last month ... case, today underwent an angiography at a ... government's JJ Hospital, where Naik was admitted ... chest pain, said he underwent the medical ...
Cached Medicine News:Health News:APEC Launches Bird Flu Exercise 2Health News:Smoking Increases Osteoporosis Risk 2Health News:Smoking Increases Osteoporosis Risk 3Health News:Intermittent Explosive Disorder is More Prevalent Now Than Before 2Health News:Intermittent Explosive Disorder is More Prevalent Now Than Before 3
Used with eye shield to cushion the eye. Eliminates need for taping shield. No sticky residue. Package 50 per box. Assorted colors....
Includes one aluminum pediatric eye shield and one eye garter shield cover. Packaged 50 per box. White only....
4 mm x 4 mm downward biting jaws, curved right, length of shaft 115 mm, overall length 9.3 inches....
45 degree, forward 3 mm, 4 mm x 5 mm cup, length of shaft 140 mm, overall length 8.3 inches....
Medicine Products: